Latest Entitlement Offer News

Micro-X Ltd has secured a $5.6 million strategic partnership with Malaysian firm Billion Prima and raised $4 million in capital, marking a pivotal shift towards medical imaging while progressing key security and health technology projects.

Corella Resources has finalised its fully underwritten entitlement offer, issuing over 300 million shortfall shares and raising a total of approximately $935,000 before costs.

Tempest Minerals has raised $400,000 through a placement and plans a $1.47 million entitlement issue to advance its gold exploration and Remorse Iron development in Western Australia.

Fletcher Building reported a challenging HY25 with a 7% revenue decline and a net loss of NZ$134 million, while executing a $700 million equity raise to strengthen its balance sheet and advancing significant cost reduction initiatives.

Ignite Limited’s half-year results reveal a 7% revenue decline but a striking 189% surge in net profit, underpinned by margin improvements and cost efficiencies. The company also announces an interim dividend, signaling confidence in its turnaround strategy.

Rapid Lithium has successfully placed the full $1 million shortfall from its recent entitlement issue, positioning the company to advance exploration projects in Canada and the USA.

Icetana Limited has successfully closed its renounceable pro rata entitlement offer, raising $629,422 through new share issuance, with convertible notes poised to convert into shares shortly.

Eagle Mountain Mining has completed a significant capital raise through the issue of over 518 million new shares and 129 million options, including a $3 million loan conversion, bolstering its exploration projects in Arizona.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.

PYC Therapeutics is set to raise up to $146 million through a pro-rata entitlement offer, aiming to accelerate its RNA-based drug candidates targeting major unmet medical needs. Major shareholder support and underwriting commitments underpin the capital raise.

Smart Parking Limited has reported robust H1 FY25 results, underpinned by a strategic acquisition of Peak Parking LP and a fully underwritten $45 million equity raise to fund its US expansion.

Smart Parking Limited is set to expand its global footprint by acquiring US-based Peak Parking LP for up to USD 36 million, backed by a fully underwritten equity raise and expanded debt facility. The deal promises significant EPS accretion and strategic growth opportunities in the lucrative US parking market.